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ABSTRACT
 
To evaluate the effects from the fresh flowers of Pithecellobium dulce (Roxb.) Benth, belonging to the
family of Leguminosae subfamily Mimosoideae, a glycoside quercitin has been isolated. The ethyl
acetate soluble of P. dulce containing the above glycoside was studied both in silico and in vitro for the
anti-inflammatory and anti-bacterial properties. The concatenation of the in silico and in vivo has been
done. Results indicated the activity of this flavonol glycoside in the protection of HRBC lysis and
against the gram positive micro organisms, thus confirming its anti-inflammatory and anti-bacterial
properties.
INTRODUCTION
Pithecellobium dulce (Roxb.) Benth, belonging to the family of Leguminosae, subfamily Mimosoideae,
is a small evergreen thorny tree1. The tree is reported to be active against veneral diseases2. The
decoction is given as enema3. The seeds contain saponin4. As there is no work on the flowers of P. dulce,
the flowers of same have now been examined for their poly-phenolic constituents. The crude extract of
the flowers has also been investigated in silico and in vitro for their anti-inflammatory and anti-bacterial
properties and our results are presented in this communication.
METHODOLOGY
From the fresh flowers (300g) of P. dulce collected from Thanjavur district of Tamilnadu, India, during
February, were dried in shade and extracted with 80% ethanol in cold. The combined alcoholic extract
was concentrated in vacuum and the aqueous concentrate was successfully fractionated with benzene,
peroxide free Et2O and EtOAc. The benzene fraction did not yield any crystalline solid. The residue
from the EtOAc fraction was taken up in minimum quantity of Me2CO and left in an ice chest for about
a week when yellow solid separated. On re-crystallization from aqueous methanol, it came out as pale
yellow needles, m.p 313-315C (yield 0.01 %).
 
                  255,269sh, 370 ;(MeOH+NaOMe):262sh,321,420(dec.);(MeOH+AlCl3):
 267,303,458 ;( MeOH+AlCl3+HCl):267,303,351,428;(MeOH+NaOAc): 
 275,328,390 ;( MeOH+NaOAc+H3BO3):262,303sh, 386;
                           red color with Mg-HCl5, Olive green color with alc.Fe3+, golden yellow         
                           color with NH3 and NaOH, yellow solution with pale green fluorescence       
                           with conc.H2SO4, yellow under UV/NH3, responded to Horhammer-
                           Hansel 19, Wilson’s boric acid test 20 and Gibbs test21 test indicative of a        
                           flavonol 3-O glycoside and the identity was confirmed by co- and mixed        
                           PC with an authentic sample of quercetin.
 
The 13C- NMR data of the isolated compound is given as follows:
 
                                13C-NMR (125MHz,DMSO-D6,TMS) d ppm:157.3(C-2),134.2(C-              
                        3),178.1(C-4).162.1(C-5),99.5(C-6),165.0(C-7),94.3(C-8),157.0(C-                       
                        9),104.8(C-10),121.8(C-11),116.0(C-21),145.6(C-31),148.9(C-41),116.0(C-
                        51) and 122.0(C-61)
 
The UV and 13C- NMR spectral data were in agreement with the flavonol quercetin.
 
A solution of the glycoside was hydrolyzed (7%H2SO4, 100° C, 2 hr.) and the aglycone was
characterized as quercetin (m.m.p, uv data, Rf, acetate and methyl ether) and the sugar was identified as
rhamnose. A quantitative hydrolysis of the same by the Folin-wu’s micro method 22 revealed to be a
monoside. The glycoside was thus characterized as quercetin 3-O rhamnoside (quercitrin) and the
identity was confirmed by direct comparison with an authentic sample of quercitin. Based on the UV and
13C- NMR spectral data, it is crystal clear that the isolate is flavonol quercetin. The structure of the
quercitrin was drawn by using ACD-3D ChemSketch.5 Then we performed the conversion of the drawn
chemical structure into SMILES 7 notation, so as to predict biological activity and to find similar
chemical compounds. The SMILES notation used for screening similar compounds and biological
activity is given below.
C5(O)C(O)C(O)C2[O+]([H-]C1C(O)C(O)CCC1C3C(O2)C(O)C4C(O)CC(O)CC4O3)C5
 To find similar chemical compounds we have screened the compounds from NCI. 8 For predicting
biological activity we used PASS. 6
 
RESULTS AND DISCUSSION
Quercetin 3-O-rhamnoside (quercitrin) see figure 1, has been isolated from the fresh flowers of P. dulce.
The UV spectrum of the glycoside exhibited two major absorption peaks at 350 nm (band I) and 256 nm
(band II). The band I absorption of the glycoside is reminiscent of a flavonol skeleton. A comparison of
band I absorption of the glycoside and that of the aglycone revealed that there may be 3-glycosilation in
the flavonol. A bathochromic shift of 43 nm (band I) in NaOMe confirmed the presence of a free –OH at
C-41 .The AlCl3 spectra (with and without HCl) showed four absorption peaks to reveal the presence of
a free 5-OH group. It was confirmed by the bathochromic shift of 50 nm on the addition of AlCl3-HCl in
the glycoside. The presence of a free –OH group at C-7 was evident from the +16 nm (band II) shift on
the addition of NaOAc. The band I absorption  in AlCl3 spectrum is 30 nm more than that noticed on
addition of AlCl3-HCl.This is indicative of the existence of an  O- dihydroxyl group in the B-ring. In
the 1H-NMR spectrum (400MHz,DMSO-D6,TMS) the signal at d 6.47 and 6.42 ppm corresponds to the
A-ring protons at C-8 and C-6.The 5_OH protons resonates at d 12.56 ppm.The proton C-51 appears at d
6.86 ppm as a doublet. The signal d 10.88 ppm can be traced to the-OH at C-7 and C-21.The C-61
 protons show up at d 7.30 ppm.The methyl protons of rhamnoside moiety resonate at d1.18 nppm and
the H-1 of rhamnoside resonates at d5.31 ppm.The remaining sugar protons appear in the range of d3.37-
4.0 ppm Supporting evidence for the structure of the glycoside was provided by the analysis of 13C-
NMR (100MHz, DMSO-D6, TMS) data. Due to glycosilation at 3-position, the C-2 and C-4 carbons
absorb at d 157.3 and 178.1 ppm respectively.                                                  
                                              
Figure 1:  Quercitrin structure.
The stick model shown in this picture (color by CPK) is based on the actual chemical structure provided
by the analysis of 13C-NMR (100MHz, DMSO-D6, and TMS) data.
 
Thus on the basis of the above mentioned Physical and Chemical evidences the glycoside obtained from
P. dulce has been characterized as quercetrin. Biological activity prediction is pivotal in any structure
prediction. Based on the UV and 13C- NMR spectral data, it is crystal clear that the isolate is flavonol
quercitrin. We were much interested to predict its biological activity. So as to predict structure activity
relationship, for that the structure of the quercitrin was drawn by using ACD-3D ChemSketch v 5.12 5.
We have performed in silico studies like chemical structure similarity search and the Prediction of
Activity Spectra for Substances: PASS 6 prediction was done by converting the quercetin structure into
the Simplified Molecular Input Line Entry System (SMILES notation) 7 proposed by Dave Weininger
(Weininger, 1988). Finally we have found some similar structures in enhanced NCI database browser
release 2. 8 The obtained quercitrin structure was submitted for Pass prediction and we obtained the 41
substructure chemical descriptors. We have taken Pa >0.7 and found that the highest hit had predicted
membrane integrity agonist and anti-inflammatory activities. Because if the Pa >0.7, the substance is
very likely to exhibit the activity in experiment. The list of predicted properties by PASS Pa >0.7 is
given in the Table 1. The reliable effects and mechanisms are listed in Table 2, and 3.             
                      
Table 1: PREDICTED ACTIVITY
Pa Pi Activity
0,969 0,004 Membrane integrity agonist
0,891 0,004 Membrane permeability inhibitor
0,885 0,006 Vascular (periferal) disease treatment
0,849 0,002 Capillary fragility treatment
0,751 0,008 Topoisomerase II inhibitor
0,731 0,007 Emetic
0,728 0,006 Sweetener
0,725 0,005 Osmotic diuretic
 
 
Table: 2. PREDICTED RELIABLE EFFECTS.
 
Pa Pi Activity:
0.969 0.004 Membrane integrity agonist
0.969  0.004         Antiinflammatory
0.969  0.004         Antibacterial
0.969  0.004         Psychotropic
0.969  0.004           Antiepileptic
0.969  0.004         Immunostimulant
0.969  0.004         Antiviral (HIV)
0.969  0.004         Antiviral (herpes)
0.969  0.004         Antineoplastic
0.969  0.004         Antiprotozoal
0.969  0.004         Dermatologic
0.969  0.004          Antieczematic
0.969  0.004         Antiseborrheic
0.969  0.004          Antiischemic
0.969  0.004         Antiischemic renal
 
Table: 3.  PREDICTED MECHANISMS
 
Pa Pi Activity
0.969  0.004         Membrane integrity agonist
0.969  0.004          Antiinflammatory
0.969  0.004         Antineoplastic
0.969  0.004          Antifungal
0.969  0.004          Antiviral
0.969  0.004         Antiseborrheic
0.969  0.004         Antiviral (HIV)
So from the in silico predicted information, we have decided  to test the activity in vitro especially for
the membrane permeability inhibitor (Table-1), membrane integrity agonist (Table 1, 2, 3), anti-bacterial
effects(Table-2) and anti-inflammatory mechanisms (Table-2 & 3).
 
ANTI-INFLAMMATORY STUDIES
Lysosomal enzymes play an important role in the development of acute and chronic inflammation.9
Increased enzyme activity has been reported in certain types of experimental inflammation.10 The
inhibitory effects of non-steroidal anti–inflammatory drugs on lysosomal enzymes have been proposed as
an explanation for one of their many mechanisms of actions in vitro.11 Acidic anti-inflammatory
compounds such as phenyl butazone, Mefenamic acid and indomethacin have been shown to exert their
beneficial effect by inhibiting the activities of either released lysosomal enzyme or by stabilizing the
lysosomal membrane12-14. It has been reported that the structure of RBC is similar to that of lysosomal
membrane components.15 Since lysosomal membranes resemble human RBC (HRBC) membranes, the
lysosomal membrane effects have been studied using HRBC. When the RBC is subjected to hypotonic
stress, the release of haemoglobin from RBC is prevented by anti-inflammatory drugs because of the
membrane stabilization. Hence the HRBC membrane stabilization by drugs against hypotonicity induced
haemolysis serves as a very useful in vitro method for assessing the anti-inflammatory activity of
compounds. In this present investigation, an in vitro study of the EtOAc isolates of P.dulce by finding
the stabilization of the HRBC membrane against hypotonicity induced haemolysis has been made,16 the
results are indicated in the Table 4 and the Graph-I. From the results the in silico predicted membrane
permeability inhibitor (Table-1), membrane integrity agonist (Table 1, 2, 3), and anti-inflammatory
mechanisms (Table-2 & 3) have been understood in vitro.
 
Table: 4: Stabilization Effect of isolates of P.dulce on the HRBC membrane stabilization against hypotonicity
induced haemolysis.
 
Sl.
No
Concentration of
the drug in mg
Percentage
protection
1 10                40
2 50 58
3 100 64
4 250 70
5 500 90
 
Based on the in vitro Stabilization Effect of isolates of P.dulce on the HRBC membrane stabilization
against hypotonicity induced haemolysis, the tabular values are plotted as a graphical representation.
(Graph-I)
 
Graph-I: The in vitro Stabilization Effect of isolates of P.dulce on the HRBC membrane stabilization
against hypotonicity induced haemolysis. The concentration of the drug (in mg) used in the protection of
HRBC membrane is plotted in the graph.
 
The crude extract was observed to be effective in stabilizing the HRBC membrane against hypotonicity
induced haemolysis and hence would be effective as non steroidal anti-inflammatory compounds in the
control of inflammation. With in the experimental range of dosages of (10 to 250 mg /ml) the flavonoid
drug exhibited 70% protection at 250 mg dose and at subsequent doses, the protection increases and
reached a maximum with a sharp increase at 500 mg. At higher concentrations the activity climbs up
showing the anti-inflammatory activity of this flavonoid drug under in vitro experimental conditions
dependent upon the concentration of the drug. The membrane is stabilized by the flavonoidal drug at a
concentration of 500 mg.
 
 
 
ANTI-MICROBIAL STUDIES
In this investigation , the anti- bacterial activity of the residue of the EtOAc fraction containing the
flavonoid glycoside  isolated from the flowers of P.dulce have been studied in vitro by Petri-dish method
using Staphylococcus aureus a gram positive, Escherichia coli and Salmonella typhii two  gram negative
as test organisms. Anti-bacterials produce their effect by interfering with one or more vital metabolic
pathways in the organism. The object of the treatment with an anti-microbial drug which is higher than
the minimal effective concentration and which is maintained at that level until the organisms have been
eliminated 17.The extracts of various medicinal plants containing flavonoids have been reported to
possess anti- bacterial activity 18.A standard volume (2.5mL) of Mueller-Hinton agar medium that would
support the growth of the test organisms was added to sterile Petri–dishes. Solutions of the test
compound (EtOAc residue) at six different concentrations viz., 25, 50,100,200,300 and 400 mg/mL in
sterile water were prepared. Standards containing streptomycin at concentration of 50,100 and 200
mg/mL and a control containing no drug were prepared. A standard inoculum of a suspension of
turbidity equal to a McFarland standard 0.5 of the test organism was added to all Petri–dishes. After
inoculation, the plates were incubated at 37°C and minimum inhibitory concentration (MIC) is found out
after 48 hours of incubation. The number of colonies that grow on this subculture is then counted and
compared to the number of CFU/mL (Colony Forming Units) in the original inoculum. In the anti-
microbial studies only traces of the growth has been observed at a lower concentration of the drug. The
growth of the organism is inhibited with higher concentration.
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